| Website | hanabiosciences.com |
| Category | BioTech |
| Employees | |
| Description | Cancer drug development |
| TOTAL | $100M |
| VENTURE FUNDING TOTAL | $100M |
| Venture Round, 6/10 Warburg Pincus Deerfield Capital Management | $100M |
Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company’s lead product candidate, Marqibo(R), potentially treats acute lymphoblastic leukemia and lymphomas.
